| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.77B | 20.49B | 19.54B | 19.01B | 17.77B | 7.61B |
| Gross Profit | 12.46B | 3.63B | 5.59B | 5.96B | 3.03B | -198.60M |
| EBITDA | 3.92B | 4.81B | 5.71B | 5.62B | 4.21B | 853.40M |
| Net Income | 3.39B | 1.18B | 2.78B | 2.67B | 2.16B | -962.00M |
Balance Sheet | ||||||
| Total Assets | 43.09B | 43.94B | 43.09B | 44.26B | 50.19B | 49.72B |
| Cash, Cash Equivalents and Short-Term Investments | 8.78B | 10.20B | 8.78B | 12.66B | 16.73B | 14.17B |
| Total Debt | 12.91B | 10.62B | 12.91B | 13.45B | 15.34B | 15.92B |
| Total Liabilities | 27.02B | 26.29B | 27.02B | 27.52B | 29.94B | 26.92B |
| Stockholders Equity | 15.66B | 17.23B | 15.66B | 16.34B | 19.86B | 22.41B |
Cash Flow | ||||||
| Free Cash Flow | 2.94B | 2.58B | 2.83B | 3.73B | 7.47B | -289.20M |
| Operating Cash Flow | 4.71B | 5.21B | 4.71B | 5.05B | 9.15B | 2.83B |
| Investing Cash Flow | -3.30B | -2.76B | -3.30B | -1.44B | -490.10M | -2.32B |
| Financing Cash Flow | -4.33B | -2.65B | -4.33B | -8.78B | -5.88B | 5.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $54.19B | 12.01 | 23.14% | 0.96% | 5.24% | 20.93% | |
72 Outperform | $37.26B | 10.24 | 24.91% | ― | 4.73% | 1.55% | |
68 Neutral | $16.71B | 17.67 | 11.35% | 6.16% | 9.04% | -57.80% | |
68 Neutral | $30.52B | 12.18 | 24.66% | 1.37% | 19.66% | 49.49% | |
64 Neutral | $15.34B | 9.27 | 126.90% | 3.50% | 16.19% | 62.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | $9.68B | 47.92 | -5.17% | ― | 3.33% | -70.60% |